-The Economic Times The government is reviewing the norms for keeping buffer stocks of wheat and rice required at a particular time of the year to feed the public distribution system and welfare schemes. The demand for wheat and rice distributed through welfare schemes is expected to rise with the implementation of the food security law. "The government is looking at the issue and we are discussing it with different departments," KV Thomas,...

-Frontline The Land Acquisition Bill runs into a roadblock as political parties fail to reach an agreement on the substantive features of the draft Bill or on the amendments proposed. The efforts of the United Progressive Alliance government to broker a consensus on the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2012, which has been pending for over a year, have not paid off not because...

-The Times of India HYDERABAD: At a time when the central government is formulating ways to 'strengthen' the not-so-adequately used Right to Information Act 2005 (RTI) in the country, here is a man from AP who has been penalised by the state information commission for using the RTI a little too frequently. Turns out that E Sivaramanjaneyulu, a resident of Navapala village in Anantapur district, dashed off over 100 RTI applications,...

-The Times of India BHUBANESWAR: He zips around in a Toyota Fortuner but is listed as a below poverty line (BPL) beneficiary. Biju Janata Dal MLA Srinath Soren, from Udala in Mayurbhanj district, who declared his assets in 2009 that in no way qualify him for such benefits, nevertheless has his wife and two kids as well listed under BPL. The information was obtained through an RTI application. Soren, a first-term MLA,...

-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...